Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

The Right Tools at the Right Time to Control Crop Disease & Boost Yields

Stockhouse Media, Stockhouse.com
0 Comments| July 17, 2020

{{labelSign}}  Favorites
{{errorMessage}}




Download the episode here.
Click to enlarge

Agri-tech Company Bee Vectoring Technologies International Inc. (TSX-V: BEE, OTCQB: BEVVF, Forum) has pioneered a unique and natural precision agriculture system that uses commercially-grown bees to deliver biological crop treatments to plants. BVT helps farmers drastically reduce their use of chemical pesticides, while increasing the yield of every acre of crop they grow. It is a business that harnesses the power of nature to make the agriculture industry more sustainable, while continuing to feed the world’s growing population.

These compelling factors have helped BVT gain the attention of media across the world, farmers across the US, and investors who are building intelligent portfolios based on spotting major global trends.

On the latest Stocktalk Investor Podcast, we are joined by BVT’s CEO Ashish Malik and legal counsel James Raakman, to discuss BVT’s patent portfolio, which is an important and valuable part of the company’s growth plan.


Listen on Apple PodcastsListen on Google Podcasts

beevt.com

FULL DISCLOSURE: Bee Vectoring Technologies International Inc. is a client ofStockhouse Publishing.



{{labelSign}}  Favorites
{{errorMessage}}